Company intelligence / Profile preview

3D Imaging

USA

Ownership: Private
Development stage: Other

Overview

3D Imaging LLC advances healthcare by innovating radiochemistry applications and radiopharmaceuticals for both research and clinical imaging, supporting faster drug development and improved diagnostics. The company is active in custom synthesis, manufacturing, and distribution of research- and clinic-grade radiotracers, with clinical imaging playing a core role[2].

Therapeutic areas: OncologyOtherImmunology
Modalities: RadiopharmaceuticalRadiotracerSmall molecule (primarily as molecular tracers)
Industry: Biotech

Partnerships

GlyTherix (strategic alliance for radiopharmaceuticals in targeted oncology)

Beyond the preview

Go deeper on 3D Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3D Imaging.

Explore the full profile